X4 Pharmaceuticals

XFOR

Capitalización de mercado USD 312 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Bain Capital Life Sciences Investors Boston, Massachusetts	USD 2.91 M	–	–	–
2	TLP 2 Tri Locum Partners New York	USD 1.68 M	+USD 26.2 k	+690	+1%
3	3 Ikarian Capital Dallas, Texas	USD 1.62 M	+USD 390 k	+10,258	+22%
4	4 Point72 Asset Management Stamford, Connecticut	USD 1.58 M	–	–	–
5	5 OrbiMed New York	USD 1.33 M	–	–	–
6	6 Axa Paris, France	USD 1.11 M	-USD 1.1 k	-29	-0.1%
7	ACM 7 AIGH Capital Management Baltimore, Maryland	USD 962 k	–	–	–
8	8 BVF Inc San Francisco, California	USD 818 k	–	–	–
9	9 Vanguard Group Malvern, Pennsylvania	USD 690 k	+USD 78.6 k	+2,066	+9%
10	10 New Leaf Venture Partners New York	USD 323 k	–	–	–
11	11 SV Health Investors Boston, Massachusetts	USD 300 k	–	–	–
12	12 Worth Venture Partners Fort Lee, New Jersey	USD 278 k	–	–	–
13	13 BlackRock New York	USD 268 k	+USD 7.15 k	+188	+2%
14	14 Sio Capital Management New York	USD 267 k	–	–	–
15	15 Renaissance Technologies New York	USD 209 k	+USD 54.6 k	+1,436	+25%
16	16 Geode Capital Management Boston, Massachusetts	USD 182 k	+USD 7.95 k	+209	+3%
17	17 Boothbay Fund Management New York	USD 174 k	+USD 49.5 k	+1,300	+28%
18	18 Bank of New York Mellon New York	USD 135 k	-USD 1.14 k	-30	-0.6%
19	19 Cormorant Asset Management Boston, Massachusetts	USD 100 k	–	–	–
20	20 Millennium Management New York	USD 75 k	-USD 414 k	-10,875	-81%
21	21 Stifel Financial St. Louis, Missouri	USD 65 k	-USD 2.7 k	-71	-3%
22	22 Dimensional Fund Advisors Austin, Texas	USD 59 k	–	–	–
23	23 Northern Trust Chicago, Illinois	USD 54 k	+USD 418	+11	+0.6%
24	24 Minot Wealth Management Westwood, Massachusetts	USD 53 k	–	–	–
25	25 State Street Boston, Massachusetts	USD 53 k	–	–	–

X4 Pharmaceuticals XFOR Capitalización de mercado USD 312 M

X4 Pharmaceuticals

XFOR

Capitalización de mercado USD 312 M